{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:18:26Z","timestamp":1791400706819,"version":"4.3.3"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cystic fibrosis (CF) is associated with exaggerated and prolonged inflammation in the lungs, which contributes to lung injury, airway mucus obstruction, bronchiectasis, and loss of lung function. This hyperinflammatory phenotype appears to be caused by an imbalance between the pro- and antiinflammatory regulatory pathways, with heightened proinflammatory stimuli, a decreased counter-regulatory response, and reduced effectiveness of immune cell function and inflammatory resolution. Thus, therapies that can target this inflammatory environment would have a major impact on preventing the progression of lung disease. Because of the complex phenotype of CF inflammation, current antiinflammatory regimens have proven to be inadequate for the targeting of these multiple dysregulated pathways and effects. Several approaches using cell therapies have shown potential therapeutic benefit for the treatment of CF inflammation. This review provides an overview of the immune dysfunctions in CF and current therapeutic regimens; explores the field of cell therapy as a treatment for CF inflammation; and focuses on the various cell types used, their immunomodulatory functions, and the current approaches to mitigate the inflammatory response and reduce the long-term damage for patients with CF.<\/jats:p>","DOI":"10.1165\/rcmb.2017-0160tr","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T11:58:17Z","timestamp":1500033497000},"page":"12-20","source":"Crossref","is-referenced-by-count":17,"title":["Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation"],"prefix":"10.1093","volume":"58","author":[{"given":"Oula","family":"Khoury","sequence":"first","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barrios","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Adult Care Center, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ortega","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Adult Care Center, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Atala","sequence":"additional","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-2451","authenticated-orcid":false,"given":"Sean V.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"key":"2026012222024722100_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1513\/pats.2306009","article-title":"Revisiting cystic fibrosis transmembrane conductance regulator structure and function","volume":"1","author":"Hanrahan","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"2026012222024722100_bib2","doi-asserted-by":"crossref","first-page":"e00201","DOI":"10.1002\/phy2.201","article-title":"Amiloride-sensitive fluid resorption in NCI-H441 lung epithelia depends on an apical Cl(\u2212) conductance","volume":"2","author":"Korbmacher","year":"2014","journal-title":"Physiol Rep"},{"key":"2026012222024722100_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"2026012222024722100_bib4","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2026012222024722100_bib5","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1152\/physrev.1999.79.1.S215","article-title":"Role of CFTR in airway disease","volume":"79","author":"Pilewski","year":"1999","journal-title":"Physiol Rev"},{"key":"2026012222024722100_bib6","doi-asserted-by":"crossref","first-page":"C1222","DOI":"10.1152\/ajpcell.00362.2010","article-title":"Role of epithelial HCO3\u2212 transport in mucin secretion: lessons from cystic fibrosis","volume":"299","author":"Quinton","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026012222024722100_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"2026012222024722100_bib8","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.1073\/pnas.2634339100","article-title":"Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium","volume":"100","author":"Coakley","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222024722100_bib9","doi-asserted-by":"crossref","first-page":"C741","DOI":"10.1152\/ajpcell.00379.2005","article-title":"Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis","volume":"290","author":"Song","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026012222024722100_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"key":"2026012222024722100_bib11","doi-asserted-by":"crossref","first-page":"d1008","DOI":"10.1136\/bmj.d1008","article-title":"Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007","volume":"342","author":"George","year":"2011","journal-title":"BMJ"},{"key":"2026012222024722100_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012222024722100_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpeds.2003.09.026","article-title":"Structural airway abnormalities in infants and young children with cystic fibrosis","volume":"144","author":"Long","year":"2004","journal-title":"J Pediatr"},{"key":"2026012222024722100_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"key":"2026012222024722100_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/rcmb.2014-0250OC","article-title":"Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs","volume":"52","author":"Keiser","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222024722100_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/path.4471","article-title":"Cystic fibrosis airway epithelium remodelling: involvement of inflammation","volume":"235","author":"Adam","year":"2015","journal-title":"J Pathol"},{"key":"2026012222024722100_bib17","doi-asserted-by":"crossref","first-page":"22299","DOI":"10.1074\/jbc.M109.098566","article-title":"Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and ERK MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to Pseudomonas aeruginosa","volume":"285","author":"B\u00e9rub\u00e9","year":"2010","journal-title":"J Biol Chem"},{"key":"2026012222024722100_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI2357","article-title":"Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells","volume":"102","author":"Kelley","year":"1998","journal-title":"J Clin Invest"},{"key":"2026012222024722100_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcf.2006.12.001","article-title":"Early inflammation in the airways of a cystic fibrosis foetus","volume":"6","author":"Verhaeghe","year":"2007","journal-title":"J Cyst Fibros"},{"key":"2026012222024722100_bib20","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/1471-2164-15-726","article-title":"Gene expression in whole lung and pulmonary macrophages reflects the dynamic pathology associated with airway surface dehydration","volume":"15","author":"Saini","year":"2014","journal-title":"BMC Genomics"},{"key":"2026012222024722100_bib22","doi-asserted-by":"crossref","first-page":"18703","DOI":"10.1073\/pnas.1422091112","article-title":"pH modulates the activity and synergism of the airway surface liquid antimicrobials \u03b2-defensin-3 and LL-37","volume":"111","author":"Abou Alaiwa","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222024722100_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biocel.2014.03.002","article-title":"Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration","volume":"52","author":"Tarran","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"2026012222024722100_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","article-title":"Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis","volume":"190","author":"Rogan","year":"2004","journal-title":"J Infect Dis"},{"key":"2026012222024722100_bib25","doi-asserted-by":"crossref","first-page":"L1286","DOI":"10.1152\/ajplung.00127.2003","article-title":"Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells","volume":"285","author":"Kreiselmeier","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222024722100_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1465-9921-14-138","article-title":"Intrinsic predisposition of na\u00efve cystic fibrosis T cells to differentiate towards a Th17 phenotype","volume":"14","author":"Kushwah","year":"2013","journal-title":"Respir Res"},{"key":"2026012222024722100_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2014.03.006","article-title":"Redox balance in cystic fibrosis","volume":"52","author":"Ziady","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"2026012222024722100_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000346568","article-title":"Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils","volume":"5","author":"Zhou","year":"2013","journal-title":"J Innate Immun"},{"key":"2026012222024722100_bib29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2014-02-555268","article-title":"A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy","volume":"124","author":"Pohl","year":"2014","journal-title":"Blood"},{"key":"2026012222024722100_bib30","first-page":"529","article-title":"Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis","volume":"132","author":"Bruce","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2026012222024722100_bib31","doi-asserted-by":"crossref","first-page":"L33","DOI":"10.1152\/ajplung.2000.278.1.L33","article-title":"Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-\u03b1 and interleukin-8","volume":"278","author":"Taggart","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222024722100_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","article-title":"Association between pulmonary function and sputum biomarkers in cystic fibrosis","volume":"175","author":"Mayer-Hamblett","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib33","first-page":"597","article-title":"Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease","volume":"64","author":"D\u00f6ring","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2026012222024722100_bib34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI114298","article-title":"Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis","volume":"84","author":"Berger","year":"1989","journal-title":"J Clin Invest"},{"key":"2026012222024722100_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/rccm.201311-1932OC","article-title":"Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis\u2013like lung disease","volume":"189","author":"Gehrig","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib36","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1080\/13693780802266777","article-title":"Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions","volume":"47","author":"Rapaka","year":"2009","journal-title":"Med Mycol"},{"key":"2026012222024722100_bib37","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026012222024722100_bib38","doi-asserted-by":"crossref","first-page":"e0120912","DOI":"10.1371\/journal.pone.0120912","article-title":"High peripheral blood Th17 percent associated with poor lung function in cystic fibrosis","volume":"10","author":"Mulcahy","year":"2015","journal-title":"PLoS One"},{"key":"2026012222024722100_bib39","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/rccm.201407-1381OC","article-title":"Regulatory T-cell impairment in cystic fibrosis patients with chronic Pseudomonas infection","volume":"191","author":"Hector","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib40","doi-asserted-by":"crossref","first-page":"a009738","DOI":"10.1101\/cshperspect.a009738","article-title":"The cystic fibrosis airway microbiome","volume":"3","author":"Lynch","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026012222024722100_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM197509042931010","article-title":"Macrophages in inflammation and infection","volume":"293","author":"Dannenberg","year":"1975","journal-title":"N Engl J Med"},{"key":"2026012222024722100_bib42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00109-014-1200-z","article-title":"Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis","volume":"92","author":"Hofer","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"2026012222024722100_bib43","doi-asserted-by":"crossref","first-page":"e75667","DOI":"10.1371\/journal.pone.0075667","article-title":"Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase","volume":"8","author":"Simonin-Le Jeune","year":"2013","journal-title":"PLoS One"},{"key":"2026012222024722100_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1183\/09031936.00178508","article-title":"Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis","volume":"34","author":"Brennan","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012222024722100_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","article-title":"Innate immunity in cystic fibrosis lung disease","volume":"11","author":"Hartl","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2026012222024722100_bib46","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.201504-0657OC","article-title":"X-box\u2013binding protein 1 and innate immune responses of human cystic fibrosis alveolar macrophages","volume":"192","author":"Lubamba","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1165\/rcmb.2013-0407OC","article-title":"Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12\u2013dependent emphysema","volume":"51","author":"Trojanek","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222024722100_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI0213572","article-title":"Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis","volume":"109","author":"Vandivier","year":"2002","journal-title":"J Clin Invest"},{"key":"2026012222024722100_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/adc.2004.069419","article-title":"New insights into pulmonary inflammation in cystic fibrosis","volume":"91","author":"Rao","year":"2006","journal-title":"Arch Dis Child"},{"key":"2026012222024722100_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FPC.0000000000000113","article-title":"PharmGKB summary: ibuprofen pathways","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"2026012222024722100_bib52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.160.3.1402","article-title":"Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils","volume":"160","author":"Maloney","year":"1998","journal-title":"J Immunol"},{"key":"2026012222024722100_bib53","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/jpet.103.052449","article-title":"Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects","volume":"306","author":"Konstan","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"2026012222024722100_bib54","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200702-181OC","article-title":"Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis","volume":"176","author":"Konstan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MCP.0b013e32834b8c04","article-title":"Pulmonary exacerbations in cystic fibrosis","volume":"17","author":"Stenbit","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"2026012222024722100_bib56","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"2026012222024722100_bib57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur Respir J"},{"key":"2026012222024722100_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.phrs.2011.02.001","article-title":"Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro","volume":"63","author":"Marjanovi\u0107","year":"2011","journal-title":"Pharmacol Res"},{"key":"2026012222024722100_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7150\/ijbs.5.667","article-title":"Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages","volume":"5","author":"Yamauchi","year":"2009","journal-title":"Int J Biol Sci"},{"key":"2026012222024722100_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":"Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2026012222024722100_bib61","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"2026012222024722100_bib62","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1600-6143.2007.01771.x","article-title":"Transient airway colonization is associated with airway inflammation after lung transplantation","volume":"7","author":"Vos","year":"2007","journal-title":"Am J Transplant"},{"key":"2026012222024722100_bib63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rmed.2008.11.015","article-title":"Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis","volume":"103","author":"Gottlieb","year":"2009","journal-title":"Respir Med"},{"key":"2026012222024722100_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222024722100_bib65","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012222024722100_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0b013e31824db9da","article-title":"Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection","volume":"94","author":"Vos","year":"2012","journal-title":"Transplantation"},{"key":"2026012222024722100_bib67","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12015-011-9228-8","article-title":"Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation","volume":"7","author":"Pontikoglou","year":"2011","journal-title":"Stem Cell Rev"},{"key":"2026012222024722100_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2026012222024722100_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0000000000000545","article-title":"Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat","volume":"122","author":"Hayes","year":"2015","journal-title":"Anesthesiology"},{"key":"2026012222024722100_bib70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/thoraxjnl-2015-206813","article-title":"Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat","volume":"70","author":"Devaney","year":"2015","journal-title":"Thorax"},{"key":"2026012222024722100_bib71","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5966\/sctm.2014-0268","article-title":"Freshly thawed and continuously cultured human bone marrow\u2013derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice","volume":"4","author":"Cruz","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"2026012222024722100_bib72","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1073\/pnas.1601911113","article-title":"Human mesenchymal stromal cells reduce influenza A H5N1\u2013associated acute lung injury in vitro and in vivo","volume":"113","author":"Chan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012222024722100_bib73","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1038\/srep08733","article-title":"Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways","volume":"5","author":"Gu","year":"2015","journal-title":"Sci Rep"},{"key":"2026012222024722100_bib74","doi-asserted-by":"crossref","first-page":"5303048","DOI":"10.1155\/2016\/5303048","article-title":"ntimicrobial properties of mesenchymal stem cells: therapeutic potential for cystic fibrosis infection, and treatment","volume":"2016","author":"Sutton","year":"2016","journal-title":"Stem Cells Int"},{"key":"2026012222024722100_bib75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2017.00339","article-title":"Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide\u2013based therapies","volume":"8","author":"Alcayaga-Miranda","year":"2017","journal-title":"Front Immunol"},{"key":"2026012222024722100_bib76","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5966\/sctm.2015-0021","article-title":"In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome","volume":"4","author":"Simonson","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"2026012222024722100_bib77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026012222024722100_bib78","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/stem.2104","article-title":"Mesenchymal stromal cells prevent allostimulation in vivo and control checkpoints of th1 priming: migration of human DC to lymph nodes and NK cell activation","volume":"33","author":"Consentius","year":"2015","journal-title":"Stem Cells"},{"key":"2026012222024722100_bib79","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2478\/s11658-011-0019-7","article-title":"Perinatal sources of mesenchymal stem cells: Wharton\u2019s jelly, amnion and chorion","volume":"16","author":"Witkowska-Zimny","year":"2011","journal-title":"Cell Mol Biol Lett"},{"key":"2026012222024722100_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nbt1274","article-title":"Isolation of amniotic stem cell lines with potential for therapy","volume":"25","author":"De Coppi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2026012222024722100_bib81","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3727\/096368911X601028","article-title":"Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function","volume":"21","author":"Murphy","year":"2012","journal-title":"Cell Transplant"},{"key":"2026012222024722100_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jcmm.12715","article-title":"Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls","volume":"20","author":"Pianta","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2026012222024722100_bib83","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.exphem.2015.10.009","article-title":"Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta","volume":"44","author":"Mareschi","year":"2016","journal-title":"Exp Hematol"},{"key":"2026012222024722100_bib84","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.4049\/jimmunol.174.10.5907","article-title":"License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC","volume":"174","author":"Vlad","year":"2005","journal-title":"J Immunol"},{"key":"2026012222024722100_bib85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12015-014-9558-4","article-title":"Amniotic membrane mesenchymal cells\u2013derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets","volume":"11","author":"Pianta","year":"2015","journal-title":"Stem Cell Rev"},{"key":"2026012222024722100_bib86","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1051\/medsci\/20163204017","article-title":"Th9 cells: a new population of helper T cells [in French]","volume":"32","author":"Vegran","year":"2016","journal-title":"Med Sci (Paris)"},{"key":"2026012222024722100_bib87","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jcyt.2013.03.004","article-title":"Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice","volume":"15","author":"Vosdoganes","year":"2013","journal-title":"Cytotherapy"},{"key":"2026012222024722100_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/scrt542","article-title":"Amnion cell\u2013mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response","volume":"6","author":"Tan","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"2026012222024722100_bib89","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3727\/096368912X657657","article-title":"Human amnion epithelial cells repair established lung injury","volume":"22","author":"Vosdoganes","year":"2013","journal-title":"Cell Transplant"},{"key":"2026012222024722100_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3727\/096368912X661409","article-title":"Human amnion epithelial cells mediate lung repair by directly modulating macrophage recruitment and polarization","volume":"23","author":"Tan","year":"2014","journal-title":"Cell Transplant"},{"key":"2026012222024722100_bib91","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"key":"2026012222024722100_bib92","doi-asserted-by":"crossref","first-page":"769","DOI":"10.12659\/AOT.894785","article-title":"Higher risk of acute cellular rejection in lung transplant recipients with cystic fibrosis","volume":"20","author":"Calabrese","year":"2015","journal-title":"Ann Transplant"},{"key":"2026012222024722100_bib93","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcf.2013.12.009","article-title":"A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis","volume":"13","author":"Konstan","year":"2014","journal-title":"J Cyst Fibros"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/1\/12\/66467011\/ajrcmb_58_1_12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/1\/12\/66467011\/ajrcmb_58_1_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:03:20Z","timestamp":1769137400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/58\/1\/12\/8430588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,1]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2017-0160tr","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2018,1,1]]}}}